Esophageal Ulcer of Unknown Origin Complicated by Left Atrial Myxoma

  • Nishizaki Yuji
    Department of Cardiology, Juntendo University Graduate School of Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan
  • Yamagami Shinichiro
    Department of Cardiology, Juntendo University Graduate School of Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan
  • Hayakawa Daisuke
    Department of Cardiology, Juntendo University Graduate School of Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan
  • Takashima Shiori
    Department of Gastrointestinal Medicine, Juntendo University Graduate School of Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan
  • Nomura Osamu
    Department of Gastrointestinal Medicine, Juntendo University Graduate School of Medicine, Japan
  • Sai Eiryu
    Department of Cardiology, Juntendo University Graduate School of Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan
  • Kon Kazuyoshi
    Department of Gastrointestinal Medicine, Juntendo University Graduate School of Medicine, Japan
  • Matsuyama Shujiro
    Department of Gastrointestinal Medicine, Juntendo University Graduate School of Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan
  • Watanabe Sumio
    Department of Gastrointestinal Medicine, Juntendo University Graduate School of Medicine, Japan
  • Daida Hiroyuki
    Department of Cardiology, Juntendo University Graduate School of Medicine, Japan

この論文をさがす

抄録

Myxoma induces the onset of paraneoplastic syndromes by excreting various humoral mediators and is therefore known to present with diverse symptoms. A 40-year-old woman was admitted to our hospital for the treatment of an esophageal ulcer, the cause of which could not be identified on various examinations. Notably, a left atrial tumor was incidentally found on chest enhanced computed tomography. The esophageal ulcer, which was intractable to conventional therapy, improved with the administration of 5-aminosalicylate, a drug known to inhibit IL-1β. This inhibitory action effectively suppressed the development of myxoma-induced paraneoplastic syndrome.<br>

収録刊行物

  • Internal Medicine

    Internal Medicine 54 (11), 1365-1367, 2015

    一般社団法人 日本内科学会

参考文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ